Address
MPM Capital
601 Gateway Boulevard
Suite 350
South San Francisco, CA 94080
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30789
Relation
Renamed to
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 71| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Nevro Corp | Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. | N/A | |||
|
|
Nevro Corp | Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. | Series A | |||
|
|
Omrix Biopharmaceuticals Inc | N/A | ||||
|
|
Orexigen Therapeutics Inc | N/A | ||||
|
|
Pacira Pharmaceuticals Inc | Acute care specialty pharmaceutical company. | N/A | |||
|
|
Proteon Therapeutics Inc | Series B | ||||
|
|
Quantum Dot Corp | N/A | ||||
|
|
QuatRx Pharmaceuticals Co | N/A | ||||
|
|
Radius Health Inc | A biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of osteoporosis | Series B | |||
|
|
Rhythm Pharmaceuticals Inc | Series A | ||||
|
|
Rigel Pharmaceuticals Inc | N/A | ||||
|
|
Sonic Innovations Inc | N/A | ||||
|
|
Syndax Pharmaceuticals Inc | A clinical development company focused on novel oral therapies for cancer. | N/A | |||
|
|
Syrrx Inc | Combines high-throughput structure determination, HTS, combinatorial and medicinal chemistry together with computational methods to discover novel sma | N/A | |||
|
|
Tercica Inc | A biopharmaceutical company developing new therapeutics for endocrine system disorders. | N/A | |||
|
|
Theraclone Sciences Inc | Series B | ||||
|
|
Theraclone Sciences Inc | N/A | ||||
|
|
Valeritas Inc | N/A | ||||
|
|
VLST Corp | N/A | ||||
|
|
Xanodyne Pharmaceuticals Inc | Specialty pharmaceuticals for pain and women's health | Series D | |||
|
|
Xoft Inc | Developer of electronic brachytherapy (eBx) systems for radiation oncology applications. | Series D | |||
|
23andMe Inc | DNA testing and genome sequencing firm. | Series D Initial investment | |||
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series F Follow-on investment | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series D Follow-on investment | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series C Initial investment |